Els-Heindl S - Search Results

1

Peptide mini-scaffold facilitates JNK3 activation in cells.

Zhan X, Stoy H, Kaoud TS, Perry NA, Chen Q, Perez A, Els-Heindl S, Slagis JV, Iverson TM, Beck-Sickinger AG, Gurevich EV, Dalby KN, Gurevich VV. Zhan X, et al. Sci Rep. 2016 Feb 12;6:21025. doi: 10.1038/srep21025. Sci Rep. 2016. PMID: 26868142 Free PMC article.

2

Automated solid-phase peptide synthesis to obtain therapeutic peptides.

Mäde V, Els-Heindl S, Beck-Sickinger AG. Mäde V, et al. Beilstein J Org Chem. 2014 May 22;10:1197-212. doi: 10.3762/bjoc.10.118. eCollection 2014. Beilstein J Org Chem. 2014. PMID: 24991269 Free PMC article. Review.

3

High metabolic in vivo stability and bioavailability of a palmitoylated ghrelin receptor ligand assessed by mass spectrometry.

Kostelnik KB, Els-Heindl S, Klöting N, Baumann S, von Bergen M, Beck-Sickinger AG. Kostelnik KB, et al. Bioorg Med Chem. 2015 Jul 15;23(14):3925-32. doi: 10.1016/j.bmc.2014.12.008. Epub 2014 Dec 10. Bioorg Med Chem. 2015. PMID: 25541202

4

Integrating solid-state NMR and computational modeling to investigate the structure and dynamics of membrane-associated ghrelin.

Vortmeier G, DeLuca SH, Els-Heindl S, Chollet C, Scheidt HA, Beck-Sickinger AG, Meiler J, Huster D. Vortmeier G, et al. PLoS One. 2015 Mar 24;10(3):e0122444. doi: 10.1371/journal.pone.0122444. eCollection 2015. PLoS One. 2015. PMID: 25803439 Free PMC article.

5

Rational design of dual peptides targeting ghrelin and Y2 receptors to regulate food intake and body weight.

Kilian TM, Klöting N, Bergmann R, Els-Heindl S, Babilon S, Clément-Ziza M, Zhang Y, Beck-Sickinger AG, Chollet C. Kilian TM, et al. J Med Chem. 2015 May 28;58(10):4180-93. doi: 10.1021/jm501702q. Epub 2015 May 7. J Med Chem. 2015. PMID: 25905598

6

Bioorthogonal Labeling of Ghrelin Receptor to Facilitate Studies of Ligand-Dependent Conformational Dynamics.

Park M, Sivertsen BB, Els-Heindl S, Huber T, Holst B, Beck-Sickinger AG, Schwartz TW, Sakmar TP. Park M, et al. Chem Biol. 2015 Nov 19;22(11):1431-1436. doi: 10.1016/j.chembiol.2015.09.014. Epub 2015 Nov 5. Chem Biol. 2015. PMID: 26548612

7

C-terminus of a hexapeptidic ghrelin receptor inverse agonist can switch peptide behavior from inverse agonism to agonism.

Els-Heindl S, Bellmann-Sickert K, Beck-Sickinger AG. Els-Heindl S, et al. Biopolymers. 2016 Jan;106(1):101-8. doi: 10.1002/bip.22768. Biopolymers. 2016. PMID: 26566778

8

Adrenomedullin 2.0: Adjusting Key Levers for Metabolic Stability.

Schönauer R, Els-Heindl S, Fischer JP, Köbberling J, Riedl B, Beck-Sickinger AG. Schönauer R, et al. J Med Chem. 2016 Jun 23;59(12):5695-705. doi: 10.1021/acs.jmedchem.6b00126. Epub 2016 Jun 6. J Med Chem. 2016. PMID: 27166982

9

Development of Potent and Metabolically Stable APJ Ligands with High Therapeutic Potential.

Juhl C, Els-Heindl S, Schönauer R, Redlich G, Haaf E, Wunder F, Riedl B, Burkhardt N, Beck-Sickinger AG, Bierer D. Juhl C, et al. ChemMedChem. 2016 Nov 7;11(21):2378-2384. doi: 10.1002/cmdc.201600307. Epub 2016 Aug 25. ChemMedChem. 2016. PMID: 27558296

10

Adrenomedullin - new perspectives of a potent peptide hormone.

Schönauer R, Els-Heindl S, Beck-Sickinger AG. Schönauer R, et al. J Pept Sci. 2017 Jul;23(7-8):472-485. doi: 10.1002/psc.2953. Epub 2017 Feb 2. J Pept Sci. 2017. PMID: 28150464 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

28 results

Search Page

Filters